Viewing StudyNCT02799095

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 8:41 AM
Last Modification Date: 2024-10-26 @ 12:03 PM
Study NCT ID: NCT02799095
Status: COMPLETED
Last Update Posted: 2024-01-24
First Post: 2016-06-01
Brief Title: A Study of the Effects of ALKS 4230 Nemvaleukin Alfa on Subjects With Solid Tumors
Sponsor: Mural Oncology Inc
Organization: Mural Oncology Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Advanced Solid Tumors
Keywords:
Name View
in combination with pembrolizumab View
Immunotherapy View
IL-2 View
Interleukin-2 View
Solid tumors View
Melanoma View
Renal cell carcinoma View
Non-small-cell lung cancer View
Squamous cell carcinoma of the head and neck View